Q/C TECHNOLOGIES, INC. — Director's Dealing 2015

Dec 31, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2015-12-30

Reporting Person: Andrews Robert E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-30	Common Stock	A	48125	—	Acquired	48125	Direct

Footnotes

F1: Such shares were issued under Akers Biosciences, Inc.'s Amended and Restated 2013 Incentive Stock and Award Plan.